101 related articles for article (PubMed ID: 17726033)
21. COX-2 inhibitors in prostate cancer treatment--hold your horses?
Cheung AS; Grossmann M
Asian J Androl; 2012 Jul; 14(4):518-9. PubMed ID: 22635163
[No Abstract] [Full Text] [Related]
22. Clinical Questions #6. Does celecoxib increase cardiovascular risk?
Mayer BJ; Lamfers R; Feldstein DA
WMJ; 2005 Nov; 104(8):15-6. PubMed ID: 16425910
[No Abstract] [Full Text] [Related]
23. How direct-to-consumer television advertising for osteoarthritis drugs affects physicians' prescribing behavior.
Bradford WD; Kleit AN; Nietert PJ; Steyer T; McIlwain T; Ornstein S
Health Aff (Millwood); 2006; 25(5):1371-7. PubMed ID: 16966735
[TBL] [Abstract][Full Text] [Related]
24. Drug testing. Massive trial of Celebrex seeks to settle safety concerns.
Couzin J
Science; 2005 Dec; 310(5756):1890-1. PubMed ID: 16373546
[No Abstract] [Full Text] [Related]
25. Inhibition of COX-2 by celecoxib in the canine groove model of osteoarthritis.
Mastbergen SC; Marijnissen AC; Vianen ME; Zoer B; van Roermund PM; Bijlsma JW; Lafeber FP
Rheumatology (Oxford); 2006 Apr; 45(4):405-13. PubMed ID: 16287921
[TBL] [Abstract][Full Text] [Related]
26. Superiority, equivalence, and non-inferiority trials.
Lesaffre E
Bull NYU Hosp Jt Dis; 2008; 66(2):150-4. PubMed ID: 18537788
[TBL] [Abstract][Full Text] [Related]
27. A prospective, randomized, double-blind, multicenter comparative study on the safety and efficacy of Celecoxib and GCSB-5, dried extracts of six herbs, for the treatment of osteoarthritis of knee joint.
Park YG; Ha CW; Han CD; Bin SI; Kim HC; Jung YB; Lim HC
J Ethnopharmacol; 2013 Oct; 149(3):816-24. PubMed ID: 23954277
[TBL] [Abstract][Full Text] [Related]
28. Does celecoxib potentiate the anticoagulant effect of warfarin? A randomized, double-blind, controlled trial.
Dentali F; Douketis JD; Woods K; Thabane L; Foster G; Holbrook A; Crowther M
Ann Pharmacother; 2006; 40(7-8):1241-7. PubMed ID: 16804099
[TBL] [Abstract][Full Text] [Related]
29. Treating osteoarthritis with cyclooxygenase-2-specific inhibitors: what are the benefits of avoiding blood pressure destabilization?
Grover SA; Coupal L; Zowall H
Hypertension; 2005 Jan; 45(1):92-7. PubMed ID: 15545508
[TBL] [Abstract][Full Text] [Related]
30. Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial.
Bensen WG; Fiechtner JJ; McMillen JI; Zhao WW; Yu SS; Woods EM; Hubbard RC; Isakson PC; Verburg KM; Geis GS
Mayo Clin Proc; 1999 Nov; 74(11):1095-105. PubMed ID: 10560596
[TBL] [Abstract][Full Text] [Related]
31. Celecoxib: a COX-2 inhibitor.
Andrews SA; Wallace CK; Davis RL
Am J Manag Care; 1999 Apr; 5(4):511-8; quiz 522-4. PubMed ID: 10387389
[No Abstract] [Full Text] [Related]
32. COX-2 inhibitors. Magic bullets or merely mortal?
Harv Health Lett; 2000 Feb; 25(4):4. PubMed ID: 10637015
[No Abstract] [Full Text] [Related]
33. The cyclooxygenase-2 inhibitor celecoxib and alveolar osteitis (Journal of the Irish Dental Association 2011; 57 (1): 50-53).
Hackett JF
J Ir Dent Assoc; 2011; 57(3):127. PubMed ID: 21834146
[No Abstract] [Full Text] [Related]
34. Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison.
Cannon CP; Curtis SP; FitzGerald GA; Krum H; Kaur A; Bolognese JA; Reicin AS; Bombardier C; Weinblatt ME; van der Heijde D; Erdmann E; Laine L;
Lancet; 2006 Nov; 368(9549):1771-81. PubMed ID: 17113426
[TBL] [Abstract][Full Text] [Related]
35. Prevention of intra-abdominal adhesions using the antiangiogenic COX-2 inhibitor celecoxib.
Cahill RA
Ann Surg; 2006 Aug; 244(2):327-8; author reply 328. PubMed ID: 16858202
[No Abstract] [Full Text] [Related]
36. [Coronary risks with NSAID and coxibs. The end of hysteria].
Einecke D
MMW Fortschr Med; 2006 Nov; 148(48):10, 12. PubMed ID: 17615760
[No Abstract] [Full Text] [Related]
37. Pilot randomized phase II study of celecoxib in oral premalignant lesions.
Papadimitrakopoulou VA; William WN; Dannenberg AJ; Lippman SM; Lee JJ; Ondrey FG; Peterson DE; Feng L; Atwell A; El-Naggar AK; Nathan CO; Helman JI; Du B; Yueh B; Boyle JO
Clin Cancer Res; 2008 Apr; 14(7):2095-101. PubMed ID: 18381950
[TBL] [Abstract][Full Text] [Related]
38. Novel strategies for the treatment of lung cancer: modulation of eicosanoids.
Backlund MG; Amann JM; Johnson DH
J Clin Oncol; 2008 Feb; 26(6):825-7. PubMed ID: 18281650
[No Abstract] [Full Text] [Related]
39. Pragmatic decisions over nonsteroidal antiinflammatory drug treatment in osteoarthritis--continuous versus intermittent.
Moore RA
J Rheumatol; 2011 Dec; 38(12):2501-3. PubMed ID: 22134793
[No Abstract] [Full Text] [Related]
40. [New treatment of pain and fever in rheumatoid arthritis and arthrosis. The first cyclooxygenase-2 inhibitors show promising results].
Oliw E; Wollheim FA
Lakartidningen; 2000 Jun; 97(24):2942-4. PubMed ID: 10900877
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
